Effect of Early Administration of Casirivimab and Imdevimab in Hospitalized Patients with COVID-19: A Post Hoc Analysis

Eleftherios Mylonakis,1 Amy Sullivan,2 Selin Somersan-Karakaya,2 Xiaojun You,2 Jiangnan Lyu,2 Fadi Shehadeh,1 Gregory P Geba2 1Department of Medicine, Houston Methodist Hospital, Houston, TX, USA; 2Global Development, Regeneron Pharmaceuticals, Inc, Tarrytown, NY, USACorrespondence: Eleftherios Mylo...

Celý popis

Podrobná bibliografie

Hlavní autoři:	Mylonakis E, Sullivan A, Somersan-Karakaya S, You X, Lyu J, Shehadeh F, Geba GP
Médium:	Artigo
Jazyk:	Inglês
Vydáno:	Dove Medical Press 2026-06-01
Edice:	Infection and Drug Resistance
Témata:	casirivimab COVID-19 imdevimab monoclonal antibody time to treatment
On-line přístup:	https://www.dovepress.com/effect-of-early-administration-of-casirivimab-and-imdevimab-in-hospita-peer-reviewed-fulltext-article-IDR
Tagy:	Přidat tag Žádné tagy, Buďte první, kdo vytvoří štítek k tomuto záznamu!